As of 31st January 2020, the Committees on Advertising Practice (CAP) and Advertising Standards Authority (ASA) in association with the Medicines and Healthcare products Regulatory Agency (MHRA) has placed restrictions on how prescription-only medications can be advertised to the public and have legislated the removal of all references to such products from web and social media marketing platforms (Rule 12.12). LCIAD Face is in compliance with these requirements. Further information can be found in the links below:


Advertising Standards Authority – Beauty and cosmetics 

Advertising Standards Authority – Frequently asked questions

MHRA medicines advertising

Consequently, we would re-emphasise the importance of a comprehensive and face-to face consultation with Professor Milvia Di Gioia to ensure that you have the latest information and advice that is most suitable for your case as we are only able to recommend prescription-only facial aesthetics products after face-to-face consultation.

Please call us on 020 7323 3041 or complete our confidential Medical History Questionnaire – Face (MHQF) and Facial Aesthetics Questionnaire (FAesQ) and our team will contact you for a comprehensive facial aesthetics consultation.